I have a meeting tomorrow about a really exciting project so I will miss WL . . .
but there will be no spin. WL speaks plainly and directly to the point of achievements. The likelihood is that Arikace will be superior due to the biofilm penetrating/mucolytic effect of the liposome (go all the way back to the original patent and understand they duplicated one form of surfactant). And there may be a hint about NTM progress. Those things will completely over-arch this Russell baloney that has furthered the MMs manipulation of the stock during the last 30 days. I look to top $18 on CF/Pa alone.